Pages
Products
Synapsin-Cre-GFP AAV (Serotype 8)

Synapsin-Cre-GFP AAV (Serotype 8)

Cat.No. :  AAV00100Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 8 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00100Z
Description Synapsin-Cre-GFP AAV (Serotype 8) is the serotype 8 AAV which express Cre recombinase and GFP under two separate Synapsin promoters which restricts transgene expression only in neurons.
Serotype AAV Serotype 8
Target Gene Synapsin-Cre-GFP
Product Type Adeno-associated virus
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

As lifespan increases, the prevalence of neurodegenerative diseases increases, increasing the burden on health systems worldwide. The need for therapeutic options has driven research, with the field of gene therapy applied to central nervous system (CNS) pathologies at the forefront. Despite having witnessed many major conceptual changes recently—such as the in vivo reprogramming of different cells into neurons through genetic delivery of specific transcription factors or microRNAs—the more traditional approach of delivering therapeutic genes using viral vectors remains one of the most promising options. While both viral and nonviral vectors have been widely used for CNS gene therapy, viral vectors, including adeno-associated viruses (AAVs) and lentiviruses, are generally more efficient than nonviral vectors in delivering genes to target cells. AAVs have emerged as the most promising tool for CNS gene transfer due to their ability to transduce both dividing and non-dividing cells and induce stable, long-term gene expression in the absence of inflammation and/or toxicity. As neurons are post-mitotic cells, the ability of AAV vectors to transduce non-dividing cells is critical in gene therapy for neurodegenerative diseases. In particular, AAV serotype 8 (AAV8) has been shown to be one of the most efficient vectors in certain structures of the central nervous system, producing the highest transgene transduction rates in the striatum compared to other serotypes without neurotoxicity. Furthermore, active transport of this serotype along axons has been observed in multiple studies in different animal models.

Dopamine release in striatal circuits, including the nucleus accumbens (NAc), tracks dissociable features of reward, such as motivation and reinforcement. Here, researchers show that dopamine D3 receptor (D3R) signaling in the NAc drives motivated behavior by modulating local NAc microcircuits. Furthermore, D3Rs are co-expressed with dopamine D1 receptors (D1Rs), which modulate reinforcement but not motivation. Parallel to the dissociable roles in reward function, researchers report non-overlapping physiological actions for D3R and D1R signaling in NAc neurons. These findings establish a new cellular framework in which dopamine signaling within the same NAc cell type is physiologically distinguished by actions at distinct dopamine receptors. This structural and functional organization provides neurons in limbic circuits with a unique ability to coordinate dissociable aspects of reward-related behaviors that are relevant to the etiology of neuropsychiatric disorders.

To specifically assess whether D3Rs acting on MSNs within the NAc microcircuitry are drivers of motivation, researchers implemented novel functional disconnection procedures, including pharmacological antagonism and cKO of NAc D3Rs (Figure 1c). In these experiments, control Drd3fl/fl mice were microinfused directly with SB-277011A and injected with AAV-hSyn-GFP-Cre into the NAc (Figure 1d). In this group, the unmanipulated hemisphere still had intact D3R signaling, thus supporting motivated behaviors (Figure 1e-f). The experimental group (contralateral Drd3fl/fl mice) underwent a functional disconnection in which unilateral NAc microinjections of SB-277011A and AAV-hSyn-GFP-Cre were performed in the contralateral hemisphere. Under these conditions, only D3R signaling in MSNs within the NAc underwent bilateral disruption (Figure 1d). Researchers hypothesized that if motivated running behavior is independent of local D3R signaling, then manipulating D3R activity in each hemisphere independently should not disrupt NAc D3R-mediated motivation. On the other hand, if motivation is mediated by local D3R signaling, then contralateral disconnection should disrupt motivation. Indeed, contralateral Drd3fl/fl mice exhibited motivational deficits as evidenced by reduced running behavior and preference for a freely moving disk compared to ipsilateral mice (Figure 1e-f). These results suggest that D3Rs acting on local MSNs within the NAc microcircuit are necessary for motivated behavior in mice.

Motivated behavior requires local D3R signaling within the NAc.Figure 1. Motivated behavior requires local D3R signaling within the NAc. (Enriquez-Traba J, et al., 2023)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Excellent Packaging

The product arrives well-packaged, ensuring that the viral vectors maintain their integrity until use. Moreover, the technical support team is knowledgeable and responsive, helping us optimize our protocol for the best performance.

Germany

03/25/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction